Perritt Capital Management Inc Opiant Pharmaceuticals, Inc. Transaction History

Perritt Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$19.54 - $33.59 $29,310 - $50,385	-1,500 Reduced 4.69%	30,500 $653,000
Q4 2020 Feb 16, 2021	BUY	$6.87 - $8.88 $17,175 - $22,200	2,500 Added 8.47%	32,000 $257,000
Q2 2020 Aug 13, 2020	SELL	$8.64 - $11.87 $69,120 - $94,960	-8,000 Reduced 21.33%	29,500 $266,000
Q1 2020 May 15, 2020	BUY	$9.11 - $14.42 $13,665 - $21,630	1,500 Added 4.17%	37,500 $359,000
Q4 2019 Feb 05, 2020	BUY	$13.16 - $15.96 $32,900 - $39,900	2,500 Added 7.46%	36,000 $518,000
Q3 2019 Nov 12, 2019	BUY	$11.26 - $16.48 $377,210 - $552,080	33,500 New	33,500 $504,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Perritt Capital Management Inc with notifications on news.